Intensive care unit-acquired Stenotrophomonas maltophilia:: incidence, risk factors, and outcome

被引:84
|
作者
Nseir, Saad
Di Pompeo, Christophe
Brisson, Helene
Dewavrin, Florent
Tissier, Stephanie
Diarra, Maimouna
Boulo, Marie
Durocher, Alain
机构
[1] Univ Hosp Lille, Calmette Hosp, Intens Care Unit, F-59037 Lille, France
[2] Univ Lille 2, Med Assessment Lab, F-59045 Lille, France
来源
CRITICAL CARE | 2006年 / 10卷 / 05期
关键词
D O I
10.1186/cc5063
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction The aim of this study was to determine incidence, risk factors, and impact on outcome of intensive care unit (ICU)acquired Stenotrophomonas maltophilia. Methods This prospective observational case-control study, which was a part of a cohort study, was conducted in a 30-bed ICU during a three year period. All immunocompetent patients hospitalised > 48 hours were eligible. Patients with non-fermenting Gram-negative bacilli (NF-GNB) at ICU admission were excluded. Patients without ICU-acquired S. maltophilia who developed an ICU-acquired NF-GNB other than S. maltophilia were also excluded. Screening ( tracheal aspirate and skin, anal, and nasal swabs) for NF-GNB was performed in all patients at ICU admission and weekly. Univariate and multivariate analyses were performed to determine risk factors for ICU-acquired S. maltophilia and for ICU mortality. Results Thirty-eight (2%) patients developed an S. maltophilia ICU-acquired colonisation and/or infection and were all successfully matched with 76 controls. Chronic obstructive pulmonary disease ( COPD) and duration of antibiotic treatment ( odds ratio [ OR] [ 95% confidence interval (CI)] = 9.4 [ 3 to 29], p < 0.001, and 1.4 [ 1 to 2.3], p = 0.001, respectively) were independently associated with ICU-acquired S. maltophilia. Mortality rate (60% versus 40%, OR [ 95% CI] = 1.3 [ 1 to 1.7, p = 0.037]), duration of mechanical ventilation ( 23 +/- 16 versus 7 +/- 11 days, p < 0.001), and duration of ICU stay ( 29 +/- 21 versus 15 +/- 17 days, p < 0.001) were significantly higher in cases than in controls. In addition, ICU-acquired infection related to S. maltophilia was independently associated with ICU mortality ( OR [ 95% CI] = 2.8 [ 1 to 7.7], p = 0.044). Conclusion COPD and duration of antibiotic treatment are independent risk factors for ICU-acquired S. maltophilia. ICU-acquired S. maltophilia is associated with increased morbidity and mortality rates. ICU-acquired infection related to S. maltophilia is an independent risk factor for ICU mortality.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Polymicrobial intensive care unit-acquired pneumonia: prevalence, microbiology and outcome
    Miquel Ferrer
    Leonardo Filippo Difrancesco
    Adamantia Liapikou
    Mariano Rinaudo
    Marco Carbonara
    Gianluigi Li Bassi
    Albert Gabarrus
    Antoni Torres
    Critical Care, 19
  • [22] Polymicrobial intensive care unit-acquired pneumonia: prevalence, microbiology and outcome
    Ferrer, Miquel
    Filippo Difrancesco, Leonardo
    Liapikou, Adamantia
    Rinaudo, Mariano
    Carbonara, Marco
    Li Bassi, Gianluigi
    Gabarrus, Albert
    Torres, Antoni
    CRITICAL CARE, 2015, 19
  • [23] Clinical aspects and risk factors of nosocomial Stenotrophomonas maltophilia Bacteremia episodes in a Turkish intensive care unit
    Tunger, O.
    Vural, S.
    Cetin, C. B.
    Keles, G.
    Borand, H.
    Gazi, H.
    JOURNAL OF CHEMOTHERAPY, 2007, 19 (06) : 658 - 664
  • [24] Pneumothorax in the intensive care unit -: Incidence, risk factors, and outcome
    de Lassence, A
    Timsit, JF
    Tafflet, M
    Azoulay, É
    Jamali, S
    Vincent, F
    Cohen, Y
    Garrouste-Orgeas, M
    Alberti, C
    Dreyfuss, D
    ANESTHESIOLOGY, 2006, 104 (01) : 5 - 13
  • [25] Intensive Care Unit-Acquired Weakness: Neuropathology
    Swash, Michael
    de Carvalho, Mamede
    JOURNAL OF CLINICAL NEUROPHYSIOLOGY, 2020, 37 (03) : 197 - 199
  • [26] Intensive care unit-acquired weakness Reply
    Griffiths, Richard D.
    Hall, Jesse B.
    CRITICAL CARE MEDICINE, 2010, 38 (07) : 1619 - 1619
  • [27] Pathophysiology of intensive care unit-acquired anemia
    Fink, MP
    CRITICAL CARE, 2004, 8 (Suppl 2): : S9 - S10
  • [28] Glycemic variability as a risk factor of intensive care unit-acquired weakness
    R Mörgeli
    T Wollersheim
    S Koch
    K Haas
    M Krebs
    S Weber-Carstens
    Intensive Care Medicine Experimental, 3 (Suppl 1)
  • [29] Risk factors for intensive care unit-acquired weakness: A systematic review and meta-analysis
    Yang, Tao
    Li, Zhiqiang
    Jiang, Li
    Wang, Yinhua
    Xi, Xiuming
    ACTA NEUROLOGICA SCANDINAVICA, 2018, 138 (02): : 104 - 114
  • [30] Corticosteroids and intensive care unit-acquired pneumonia
    Klompas, Michael
    CRITICAL CARE MEDICINE, 2012, 40 (09) : 2710 - 2712